Do you want to buy antibiotics online without prescription? http://buyantibiotics24h.com/ - This is pharmacy online for you!

2010eye.com.hk

Publication list of Dr. Timothy Y Y Lai
PubMed indexed journal articles: 141 (as of February 2014)

1. Liu K, Chen LJ, Lai TY, Yam PO, Ho M, Chiang SW, Liu DT, Young AL, Yang Z,
Pang CP. Genes in the High-Density Lipoprotein Metabolic Pathway in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy. Ophthalmology. 2014 Jan 3. pi : S0161-6420(13)01049-X. [Epub ahead of print] Jiang LB, Shen CY, Chen F, Yan WY, Lai TY, Wang NL. Clinical features of
retinal diseases masquerading as retrobulbar optic neuritis. Chin Med J (Engl).
2013;126(17):3301-6.
Yang MM, Lai TY, Tam PO, Chiang SW, Ng TK, Rong SS, Pang CP. Association
of CFH and SERPING1 polymorphisms with anterior uveitis. Br J Ophthalmol.
2013 Nov;97(11):1475-80.
Yang MM, Lai TY, Luk FO, Pang CP. The roles of genetic factors in uveitis and
their clinical significance. Retina. 2014 Jan;34(1):1-11.
Luk FO, Chan CK, Lai TY. A case of dengue maculopathy with spontaneous
recovery. Case Rep Ophthalmol. 2013 Jun 8;4(2):28-33.
Zhang X, Lai TY, Chiang SW, Tam PO, Liu DT, Chan CK, Pang CP, Zhao C, Chen LJ.
Contribution of SNRNP200 sequence variations to retinitis pigmentosa. Eye
(Lond). 2013 Oct;27(10):1204-13.
Fong AH, Lai TY. Long-term effectiveness of ranibizumab for age-related
macular degeneration and diabetic macular edema. Clin Interv Aging.
2013;8:467-83.
Chen X, Zhao K, Sheng X, Li Y, Gao X, Zhang X, Kang X, Pan X, Liu Y, Jiang C, Shi
H, Chen X, Rong W, Chen LJ, Lai TY, Liu Y, Wang X, Yuan S, Liu Q, Vollrath D,
Pang CP, Zhao C. Targeted sequencing of 179 genes associated with
hereditary retinal dystrophies and 10 candidate genes identifies novel and
known mutations in patients with various retinal diseases. Invest Ophthalmol
Vis Sci. 2013 Mar 1;54(3):2186-97.
Chan CK, Wu ZH, Luk FO, Liu DT, Fan AH, Lee VY, Lai TY. Clinical
characteristics of intermediate uveitis in Chinese patients. Ocul Immunol Inflamm. 2013;21(1):71-6.
10. Liu K, Chen LJ, Tam PO, Shi Y, Lai TY, Liu DT, Chiang SW, Yang M, Yang Z, Pang
CP. Associations of the C2-CFB-RDBP-SKIV2L locus with age-related macular degeneration and polypoidal choroidal vasculopathy. Ophthalmology. 2013 Apr;120(4):837-43. 11. Nakata I, Yamashiro K, Akagi-Kurashige Y, Miyake M, Kumagai K, Tsujikawa A, Liu K, Chen LJ, Liu DT, Lai TY, Sakurada Y, Yoneyama S, Cheng CY, Cackett P, Yeo
IY, Tay WT, Cornes BK, Vithana EN, Aung T, Matsuo K, Matsuda F, Wong TY,
Iijima H, Pang CP, Yoshimura N. Association of genetic variants on 8p21 and
4q12 with age-related macular degeneration in Asian populations. Invest
Ophthalmol Vis Sci. 2012 Sep 25;53(10):6576-81.

12. Mansour AM, Mackensen F, Mahendradas P, Khairal ah M, Lai TY, Bashshur Z.
Five-year visual results of intravitreal bevacizumab in refractory inflammatory ocular neovascularization. Clin Ophthalmol. 2012;6:1233-7.
13. Lai TY. Anti-vascular endothelial growth factor therapy for myopic choroidal
neovascularization: do we need more evidence? Retina. 2012 Sep;32(8):1443-5.
14. Yang MM, Lai TY, Tam PO, Chiang SW, Chan CK, Luk FO, Ng TK, Pang CP.
Complement factor H and interleukin gene polymorphisms in patients with non-infectious intermediate and posterior uveitis. Mol Vis. 2012;18:1865-72.
15. Yang MM, Lai TY, Tam PO, Chiang SW, Ng TK, Liu K, Pang CP. Association of
C2 and CFB polymorphisms with anterior uveitis. Invest Ophthalmol Vis Sci. 2012 Jul 27;53(8):4969-74.
16. Mansour AM, Arevalo JF, Fardeau C, Hrisomalos EN, Chan WM, Lai TY,
Ziemssen F, Ness T, Sibai AM, Mackensen F, Wolf A, Hrisomalos N, Heiligenhaus A, Spital G, Jo Y, Gomi F, Ikuno Y, Akesbi J, LeHoang P, Adan A, Mahendradas P, Khairal ah M, Guthoff R, Ghandour B, Küçükerdönmez C, Kurup SK. Three-year visual and anatomic results of administrating intravitreal bevacizumab in inflammatory ocular neovascularization. Can J Ophthalmol. 2012 Jun;47(3):269-74.
17. Lai TY, Luk FO, Lee GK, Lam DS. Long-term outcome of intravitreal
anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization. Eye (Lond). 2012 Jul;26(7):1004-11.
18. Neelam K, Cheung CM, Ohno-Matsui K, Lai TY, Wong TY. Choroidal
neovascularization in pathological myopia. Prog Retin Eye Res. 2012 Sep;31(5):495-525.
19. Wong VW, Chan CK, Leung DY, Lai TY. Long-term results of oral valganciclovir
for treatment of anterior segment inflammation secondary to cytomegalovirus infection. Clin Ophthalmol. 2012;6:595-600.
20. Liang XY, Lai TY, Liu DT, Fan AH, Chen LJ, Tam PO, Chiang SW, Ng TK, Lam DS,
Pang CP. Differentiation of exudative age-related macular degeneration and polypoidal choroidal vasculopathy in the ARMS2/HTRA1 locus. Invest Ophthalmol Vis Sci. 2012 May 31;53(6):3175-82.
21. Koh A, Lee WK, Chen LJ, Chen SJ, Hashad Y, Kim H, Lai TY, Pilz S,
Ruamviboonsuk P, Tokaji E, Weisberger A, Lim TH. EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina. 2012 Sep;32(8):1453-64.
22. Chan CK, Lai TY, Mohamed S, Lee VY, Liu DT, Li CL, Lam DS. Combined
high-dose sub-tenon triamcinolone, intravitreal bevacizumab, and laser photocoagulation for refractory diabetic macular edema: a pilot study. Retina. 2012 Apr;32(4):672-8
23. Wu ZH, Chan RP, Luk FO, Liu DT, Chan CC, Lam DS, Lai TY. Review of clinical
features, microbiological spectrum and treatment outcomes of endogenous endophthalmitis over an 8-year period. J Ophthalmol. 2012;2012:265078.
24. Yang MM, Lai TY, Tam PO, Chiang SW, Chan CK, Luk FO, Ng TK, Pang CP. CFH
184G as a genetic risk marker for anterior uveitis in Chinese females. Mol Vis. 2011;17:2655-64.
25. Jiang L, Zhang H, Xie J, Jiao X, Zhou H, Ji H, Lai TY, Wang N. Application of
multifocal visual evoked potentials in the assessment of visual dysfunction in macular diseases. Eye (Lond). 2011 Oct;25(10):1302-9.
26. Wong VW, Lai TY, Chi SC, Lam DS. Pediatric ocular surface infections: a 5-year
review of demographics, clinical features, risk factors, microbiological results, and treatment. Cornea. 2011 Sep;30(9):995-1002.
27. Lai TY, Lee GK, Luk FO, Lam DS. Intravitreal ranibizumab with or without
photodynamic therapy for the treatment of symptomatic polypoidal choroidal vasculopathy. Retina. 2011 Sep;31(8):1581-8.
28. Wu ZH, Lai RY, Yip YW, Chan WM, Lam DS, Lai TY. Improvement in multifocal
electroretinography after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy: a randomized placebo-controlled trial. Retina. 2011 Jul-Aug;31(7):1378-86.
29. Ng WW, Wu ZH, Lai TY. Half-dose verteporfin photodynamic therapy for bul ous
variant of central serous chorioretinopathy: a case report. J Med Case Reports. 2011 May 26;5(1):208.
30. Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF; American Academy of
Ophthalmology. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology. 2011 Feb;118(2):415-22.
31. Fok AC, Chan PP, Lam DS, Lai TY. Risk factors for recurrence of serous macular
detachment in untreated patients with central serous chorioretinopathy. Ophthalmic Res. 2011;46(3):160-3.
32. Chan RP, Lai TY. Photodynamic therapy with verteporfin for vasoproliferative
tumour of the retina. Acta Ophthalmol. 2010 Sep;88(6):711-2.
33. Zhang X, Chen LJ, Law JP, Lai TY, Chiang SW, Tam PO, Chu KY, Wang N, Zhang M,
Pang CP. Differential pattern of RP1 mutations in retinitis pigmentosa. Mol Vis. 2010 Jul 15;16:1353-60. 34. Wong RL, Hou P, Choy KW, Chiang SW, Tam PO, Li H, Chan WM, Lam DS, Pang CP, Lai TY. Novel and homozygous BEST1 mutations in Chinese patients with Best
vitelliform macular dystrophy. Retina. 2010 May;30(5):820-7.

35. Yip YW, Ngai JW, Fok AC, Lai RY, Li H, Lam DS, Lai TY. Correlation between
functional and anatomical assessments by multifocal electroretinography and optical coherence tomography in central serous chorioretinopathy. Doc Ophthalmol. 2010 Apr;120(2):193-200.
36. Yip YW, Fok AC, Ngai JW, Lai RY, Lam DS, Lai TY. Changes in first- and
second-order multifocal electroretinography in idiopathic macular hole and their correlations with macular hole diameter and visual acuity. Graefes Arch Clin Exp Ophthalmol. 2010 Apr;248(4):477-84.
37. Chen LJ, Lai TY, Tam PO, Chiang SW, Zhang X, Lam S, Lai RY, Lam DS, Pang CP.
Compound heterozygosity of two novel truncation mutations in RP1 causing autosomal recessive retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2010 Apr;51(4):2236-42.
38. Yang Y, Zhang X, Chen LJ, Chiang SW, Tam PO, Lai TY, Chan CK, Wang N, Lam DS,
Pang CP. Association of NR2E3 but not NRL mutations with retinitis pigmentosa in the Chinese population. Invest Ophthalmol Vis Sci. 2010 Apr;51(4):2229-35.
39. Lai TY, Chu KO, Chan KP, Ng TK, Yam GH, Lam DS, Pang CP. Alterations in serum
fatty acid concentrations and desaturase activities in Bietti crystalline dystrophy unaffected by CYP4V2 genotypes. Invest Ophthalmol Vis Sci. 2010 Feb;51(2):1092-7.
40. Lai TY, Lam CP, Luk FO, Chan RP, Chan WM, Liu DT, Lam DS. Photodynamic
therapy with or without intravitreal triamcinolone acetonide for symptomatic polypoidal choroidal vasculopathy. J Ocul Pharmacol Ther. 2010 Feb;26(1):91-5.
41. Liu J, Choy KW, Chan LW, Leung TY, Tam PO, Chiang SW, Lam DS, Pang CP, Lai TY.
Tyrosinase gene (TYR) mutations in Chinese patients with oculocutaneous albinism type 1. Clin Experiment Ophthalmol. 2010 Jan;38(1):37-42.
42. Chan CK, Mohamed S, Lee VY, Lai TY, Shanmugam MP, Lam DS. Intravitreal
dexamethasone for diabetic macular edema: a pilot study. Ophthalmic Surg Lasers Imaging. 2010 Jan-Feb;41(1):26-30.
43. Lai TY, Liu DT, Chan KP, Luk FO, Pang CP, Lam DS. Visual outcomes and growth
factor changes of two dosages of intravitreal bevacizumab for neovascularage-related macular degeneration: a randomized, controlled trial. Retina. 2009 Oct;29(9):1218-26.
44. Wong VW, Chu KO, Lam PT, Yam GH, Lai TY. Late appearance of an intracameral
ophthalmic ointment globule after uneventful phacoemulsification. Jpn J Ophthalmol. 2009 Sep;53(5):553-5.
45. Mohamed S, Leung GM, Chan CK, Lai TY, Lee VY, Liu DT, Li KK, Li PS, Lam DS.
Factors associated with variability in response of diabetic macular oedema after intravitreal triamcinolone. Clin Experiment Ophthalmol. 2009 Aug;37(6):602-8.
46. Lai TY, Ngai JW, Lai RY, Lam DS. Multifocal electroretinography changes in
patients on ethambutol therapy. Eye (Lond). 2009 Aug;23(8):1707-13.
47. Lai TY, Chan WM, Liu DT, Lam DS. Intravitreal ranibizumab for the primary
treatment of choroidal neovascularization secondary to pathologic myopia. Retina 2009 Jun;29(6):750-6.
48. Lai TY, Chan RP, Chan CK, Lam DS. Effects of the duration of initial oral
corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease. Eye (Lond). 2009 Mar;23(3):543-8.
49. Lam DS, Lai TY, Lee VY, Chan CK, Liu DT, Mohamed S, Li CL. Efficacy of 1.25 MG
versus 2.5 MG intravitreal bevacizumab for diabetic macular edema: six-month results of a randomized control ed trial. Retina. 2009 Mar;29(3):292-9.
50. Chan WM, Lai TY, Liu DT, Lam DS. Intravitreal bevacizumab (Avastin) for myopic
choroidal neovascularisation: 1-year results of a prospective pilot study. Br J Ophthalmol. 2009 Feb;93(2):150-4.
51. Luk FO, Kwok AK, Lai TY, Lam DS. Presence of crystalline lens as a protective
factor for the late development of open angle glaucoma after vitrectomy. Retina. 2009 Feb;29(2):218-24.
52. Chan WM, Lai TY, Lai RY, Liu DT, Lam DS. Half-dose verteporfin
photodynamictherapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. Ophthalmology. 2008 Oct;115(10):1756-65.
53. Tsang CW, Cheung BT, Lam RF, Lee GK, Yuen CY, Lai TY, Lam DS. Primary
23-gauge transconjunctival sutureless vitrectomy for rhegmatogenous retinal detachment. Retina. 2008 Oct;28(8):1075-81.
54. Chan WM, Lai TY, Chan KP, Li H, Liu DT, Lam DS, Pang CP. Changes in aqueous
vascular endothelial growth factor and pigment epithelial-derived factor levels following intravitreal bevacizumab injections for choroidal neovascularization secondary to age-related macular degeneration or pathologic myopia. Retina. 2008 Oct;28(9):1308-13. 55. Mansour AM, Mackensen F, Arevalo JF, Ziemssen F, Mahendradas P, Mehio-Sibai A, Hrisomalos N, Lai TY, Dodwell D, Chan WM, Ness T, Banker AS, Pai SA,
Berrocal MH, Tohme R, Heiligenhaus A, Bashshur ZF, Khairallah M, Salem KM,
Hrisomalos FN, Wood MH, Heriot W, Adan A, Kumar A, Lim L, Hall A, Becker M.
Intravitreal bevacizumab in inflammatory ocular neovascularization. Am J
Ophthalmol. 2008 Sep;146(3):410-416. Epub 2008 Jul 10.

56. Lai TY, Chan WM, Liu DT, Luk FO, Lam DS. Intravitreal bevacizumab (Avastin)
with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy. Br J Ophthalmol. 2008 May;92(5):661-6. Epub 2008 Mar 20.
57. Lai TY, Fan DS, Lai WW, Lam DS. Peripheral and posterior pole retinal lesions in
association with high myopia: a cross-sectional community-based study in Hong Kong. Eye (Lond). 2008 Feb;22(2):209-13.
58. Lai TY, Lai RY, Ngai JW, Chan WM, Li H, Lam DS. First and second-order kernel
multifocal electroretinography abnormalities in acute central serous chorioretinopathy. Doc Ophthalmol. 2008 Jan;116(1):29-40. Epub 2007 Aug 29.
59. Chan WM, Lai TY, Lai RY, Tang EW, Liu DT, Lam DS. Safety enhanced
photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study. Retina. 2008 Jan;28(1):85-93. 60. Chan WM, Lai TY, Lau TT, Lee VY, Liu DT, Lam DS. Combined photodynamic
therapy and intravitreal triamcinolone for choroidal neovascularization secondary to punctate inner choroidopathy or of idiopathic origin: one-year results of a prospective series. Retina. 2008 Jan;28(1):71-80.
61. Lai TY, Chan WM, Liu DT, Lam DS. Ranibizumab for retinal angiomatous
proliferation in neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2007 Dec;245(12):1877-80.
62. Chan WM, Lai TY, Liu DT, Lam DS. Intravitreal bevacizumab (Avastin) for myopic
choroidal neovascularization: six-month results of a prospective pilot study. Ophthalmology. 2007 Dec;114(12):2190-6.
63. Lam DS, Chan CK, Mohamed S, Lai TY, Lee VY, Liu DT, Li KK, Li PS, Shanmugam
MP. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes. Ophthalmology. 2007 Dec;114(12):2162-7.
64. Lai TY, Ng TK, Tam PO, Yam GH, Ngai JW, Chan WM, Liu DT, Lam DS, Pang CP.
Genotype phenotype analysis of Bietti's crystal ine dystrophy in patients with CYP4V2 mutations. Invest Ophthalmol Vis Sci. 2007 Nov;48(11):5212-20.
65. Lai TY, Wong VW, Lam RF, Cheng AC, Lam DS, Leung GM. Quality of reporting of
key methodological items of randomized controlled trials in clinical ophthalmic journals. Ophthalmic Epidemiol. 2007 Nov-Dec;14 (6):390-8. Review.
66. Lai TY, Mohamed S, Chan WM, Lai RY, Lam DS. Multifocal electroretinography in
dengue fever-associated maculopathy. Br J Ophthalmol. 2007 Aug;91(8):1084-5.
67. Lee GK, Lai TY, Chan WM, Lam DS. Retinal pigment epithelial tear following
intravitreal ranibizumab injections for neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2007 Aug;245(8):1225-7.
68. Chan WM, Lai TY, Liu DT, Lam DS. Intravitreal bevacizumab (avastin) for choroidal
neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin. Am J Ophthalmol. 2007 Jun;143(6):977-983. Epub 2007 Apr 24. 69. Cheung BT, Lai TY, Yuen CY, Lai WW, Tsang CW, Lam DS. Results of high-density
silicone oil as a tamponade agent in macular hole retinal detachment in patients with high myopia. Br J Ophthalmol. 2007 Jun;91(6):719-21.
70. Fok AC, Lai TY, Wong VW, Wong AL, Lam DS. Spontaneous resolution of retinal
pigment epithelial tears and pigment epithelial detachment fol owing blunt trauma. Eye (Lond). 2007 Jun;21(6):891-3.
71. Chan WM, Lai TY, Wong AL, Liu DT, Lam DS. Combined photodynamic therapy
and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study. Br J Ophthalmol. 2007 Feb;91(2):174-9.
72. Lam DS, Chan CK, Mohamed S, Lai TY, Li KK, Li PS, Tsang CW, Chan WM,
Shanmugam MP. A prospective randomised trial of different doses of intravitreal triamcinolone for diabetic macular oedema. Br J Ophthalmol. 2007 Feb;91(2):199-203.
73. Lai TY, Kwok AK, Au AW, Lam DS. Assessment of macular function by multifocal
electroretinography following epiretinal membrane surgery with indocyanine green-assisted internal limiting membrane peeling. Graefes Arch Clin Exp Ophthalmol. 2007 Jan;245(1):148-54.
74. Wong VW, Lai TY, Lee GK, Lam PT, Lam DS. Safety and efficacy of micro-incisional
cataract surgery with bimanual phacoemulsification for white mature cataract. Ophthalmologica. 2007;221(1):24-8.
75. Lai TY, Chan WM, Lai RY, Ngai JW, Li H, Lam DS. The clinical applications of
multifocal electroretinography: a systematic review. Surv Ophthalmol. 2007 Jan-Feb;52(1):61-96. Review.
76. Chan CK, Mohamed S, Shanmugam MP, Tsang CW, Lai TY, Lam DS. Decreasing
efficacy of repeated intravitreal triamcinolone injections in diabetic macular oedema. Br J Ophthalmol. 2006 Sep;90(9):1137-41. Epub 2006 May 17.
77. Kwok AK, Lai TY, Lee VY, Yeung YS, Chu KO, Pang CC. Effect of application
duration of 2% lidocaine jel y on aqueous lidocaine concentration for topical anesthesia in cataract surgery. Graefes Arch Clin Exp Ophthalmol. 2006
78. Lai TY, Chan WM, Li H, Lai RY, Liu DT, Lam DS. Safety enhanced photodynamic
therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study. Br J Ophthalmol. 2006 Jul;90(7):869-74.
79. Wong VW, Lai TY, Lee GK, Lam PT, Lam DS. A prospective study on trypan blue
capsule staining under air vs under viscoelastic. Eye (Lond). 2006 Jul;20(7):820-5.
80. Lai TY, Ngai JW, Chan WM, Lam DS. Visual field and multifocal
electroretinography and their correlations in patients on hydroxychloroquine therapy. Doc Ophthalmol. 2006 May;112(3):177-87.
81. Lai TY, Leung GM, Wong VW, Lam RF, Cheng AC, Lam DS. How evidence-based
are publications in clinical ophthalmic journals? Invest Ophthalmol Vis Sci. 2006 May;47(5):1831-8.
82. Tong JP, Chan WM, Liu DT, Lai TY, Choy KW, Pang CP, Lam DS. Aqueous humor
levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Am J Ophthalmol. 2006 Mar;141(3):456-62.
83. Chan WM, Lai TY, Wong AL, Tong JP, Liu DT, Lam DS. Combined photodynamic
therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study. Br J Ophthalmol. 2006 Mar;90(3):337-41.
84. Chan WM, Lai TY, Tano Y, Liu DT, Li KK, Lam DS. Photodynamic therapy in
macular diseases of asian populations: when East meets West. Jpn J Ophthalmol. 2006 Mar-Apr;50(2):161-9. Review.
85. Lai TY, Lee GK, Chan WM, Lam DS. Rapid development of severe toxic
retinopathy associated with continuous intravenous deferoxamine infusion. Br J Ophthalmol. 2006 Feb;90(2):243-4.
86. Wong VW, Lai TY, Lam PT, Lam DS. Acute Staphylococcus aureus wound
infection after temporal clear corneal phacoemulsification. Eye (Lond). 2006
87. Yip HK, Lai TY, So KF, Kwok AK. Retinal ganglion cells toxicity caused by
photosensitising effects of intravitreal indocyanine green with illumination in rat eyes. Br J Ophthalmol. 2006 Jan;90(1):99-102.
88. Tham CC, Lai JS, Poon AS, Lai TY, Lam DS. Results of trabeculectomy with
adjunctive intraoperative mitomycin C in Chinese patients with glaucoma. Ophthalmic Surg Lasers Imaging. 2006 Jan-Feb;37(1):33-41.
89. Chan WM, Liu DT, Lai TY, Li H, Tong JP, Lam DS. Extensive submacular
haemorrhage in polypoidal choroidal vasculopathy managed by sequential gas displacement and photodynamic therapy: a pilot study of one-year fol ow up. Clin Experiment Ophthalmol. 2005 Dec;33(6):611-8.
90. Lai TY, Chan WM, Li H, Lai RY, Lam DS. Multifocal electroretinographic changes in
patients receiving hydroxychloroquine therapy. Am J Ophthalmol. 2005 Nov;140(5):794-807.
91. Chan WM, Ohji M, Lai TY, Liu DT, Tano Y, Lam DS. Choroidal neovascularisation
in pathological myopia: an update in management. Br J Ophthalmol. 2005 Nov;89(11):1522-8. Review.
92. Lai TY, Kwok AK, Yeung YS, Kwan KY, Woo DC, Yuen KS, Loo AV. Immediate pars
plana vitrectomy for dislocated intravitreal lens fragments during cataract surgery. Eye (Lond). 2005 Nov;19(11):1157-62.
93. Kwok AK, Lai TY, Yip WW. Vitrectomy and gas tamponade without internal
limiting membrane peeling for myopic foveoschisis. Br J Ophthalmol. 2005 Sep;89(9):1180-3.
94. Kwok AKh, Lai TY, Yuen KS. Epiretinal membrane surgery with or without
internal limiting membrane peeling. Clin Experiment Ophthalmol. 2005 Aug;33(4):379-85.
95. Lam DS, Chan CK, Mohamed S, Lai TY, Lee VY, Lai WW, Fan DS, Chan WM
Phacoemulsification with intravitreal triamcinolone in patients with cataract and coexisting diabetic macular oedema: a 6-month prospective pilot study. Eye
96. Kwok AK, Lai TY, Wong VW. Idiopathic macular hole surgery in Chinese patients:
a randomised study to compare indocyanine green-assisted internal limiting membrane peeling with no internal limiting membrane peeling. Hong Kong Med J. 2005 Aug;11(4):259-66.
97. Wong VW, Lai TY, Lam PT, Lam DS. Prioritization of cataract surgery: visual
analogue scale versus scoring system. ANZ J Surg. 2005 Jul;75(7):587-92.
98. Kwok AK, Lai TY, Yeung CK, Yeung YS, Li WW, Chiang SW. The effects of
indocyanine green and endoil umination on rabbit retina: an electroretinographic and histological study. Br J Ophthalmol. 2005
99. Lai TY, Chan WM, Lam DS, Lim E. Multifocal electroretinogram demonstrated
macular toxicity associated with ethambutol related optic neuropathy. Br J Ophthalmol. 2005 Jun;89(6):774-5.
100. Wong VW, Lam PT, Lai TY, Lam DS. Black diaphragm aniridia intraocular lens for
aniridia and albinism. Graefes Arch Clin Exp Ophthalmol. 2005 May;243(5):501-4.
101. Fan DS, Lai TY, Cheung EY, Lam DS. Causes of childhood blindness in a school for
the visual y impaired in Hong Kong. Hong Kong Med J. 2005 Apr;11(2):85-9.
102. Kwok AK, Lai TY, Yam HF, Pang CP. TIMP-1 production in human retinal pigment
epithelial cells after laser exposure. Yan Ke Xue Bao. 2005 Mar;21(1):31-7.
103. Lai TY, Yip WW, Wong VW, Lam DS. Multifocal electroretinogram and optical
coherence tomography of commotio retinae and traumatic macular hole. Eye (Lond). 2005 Feb;19(2):219-21.
104. Kwok AK, Yeung CK, Lai TY, Chan KP, Pang CP. Effects of trypan blue on cel
viability and gene expression in human retinal pigment epithelial cel s. Br J Ophthalmol. 2004 Dec;88(12):1590-4.
105.Lai TY, Chan WM, Lam DS. Laser photocoagulation of indocyanine green
aniographically identified feeder vessels to idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol. 2004 Oct;138(4):693-4; author reply 694.
106. Kwok AK, Lai TY, Li WW, Yew DT, Wong VW. Trypan blue- and indocyanine
green-assisted epiretinal membrane surgery: clinical and histopathological studies. Eye (Lond). 2004 Sep;18(9):882-8.
107. Kwok AK, Lai TY, Li WW, Woo DC, Chan NR. Indocyanine green-assisted internal
limiting membrane removal in epiretinal membrane surgery: a clinical and histologic study. Am J Ophthalmol. 2004 Aug;138(2):194-9.
108. Chan WM, Lam DS, Lai TY, Liu DT, Li KK, Yao Y, Wong TH. Photodynamic therapy
with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series. Ophthalmology. 2004 Aug;111(8):1576-84. 109. Lai TY, Leung GM, Wong IO, Johnston JM. Do doctors act on their self-reported
intention to computerize? A follow-up population-based survey in Hong Kong. Int J Med Inform. 2004 Jun 15;73(5):415-31.
110. Leung GM, Yeung RY, Lai TY, Johnston JM, Tin KY, Wong IO, Woo PP, Ho LM.
Physicians' perceptions towards the impact of and wil ingness to pay for clinical computerization in Hong Kong. Int J Med Inform. 2004 Jun 15;73(5):403-14.
111. Lai TY, Chan WM, Lam DS. Transient reduction in retinal function revealed by
multifocal electroretinogram after photodynamic therapy. Am J Ophthalmol. 2004 May;137(5):826-33.
112.Chan WM, Lam DS, Lai TY, Tam BS, Liu DT, Chan CK. Choroidal vascular
remodel ing in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol. 2003 Dec;87(12):1453-8.
113. Kwok AK, Lai TY, Yuen KS, Tam BS, Wong VW. Macular hole surgery with or
without indocyanine green stained internal limiting membrane peeling. Clin Experiment Ophthalmol. 2003 Dec;31(6):470-5.
114. Chan WM, Lam DS, Wong TH, Lai TY, Kwok AK, Tam BS, Li KK. Photodynamic
therapy with verteporfin for subfoveal idiopathic choroidal neovascularization: one-year results from a prospective case series. Ophthalmology. 2003 Dec;110(12):2395-402.
115. Chan WM, Lam DS, Lai TY, Yuen KS, Liu DT, Chan CK, Chen WQ. Treatment of
choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin. Am J Ophthalmol. 2003 Nov;136(5):836-45.
116.Kwok AK, Lai TY, Chan NR. Epiretinal membrane formation with internal limiting
membrane wrinkling after Nd:YAG laser membranotomy in valsalva retinopathy. Am J Ophthalmol. 2003 Oct;136(4):763-6. 117. McClellan K, Lai T, Grigg J, Billson F. Penetrating keratoplasty in children: visual
and graft outcome. Br J Ophthalmol. 2003 Oct;87(10):1212-4.
118. Chan WM, Li KK, Liu DT, Lai TY, Chong KK, Lam DS. Photodynamic therapy with
verteporfin in laser-induced choroidal neovascularization. Am J Ophthalmol. 2003 Sep;136(3):565-7.
119. Kwok AK, Lai TY, Wu RM. Argon laser photocoagulation for the treatment of
idiopathic, bilateral, recurrent, diffuse retinal arterial aneurysms. Ophthalmic Surg Lasers Imaging. 2003 Sep-Oct;34(5):437-9.
120.Lai TY, Kwok AK. Iatrogenic punctate chorioretinopathy after internal limiting
membrane peeling. Am J Ophthalmol. 2003 Aug;136(2):396; author reply 96-7.
121. Kwok AK, Lai TY, Yew DT, Li WW. Internal limiting membrane staining with
various concentrations of indocyanine green dye under air in macular surgeries. Am J Ophthalmol. 2003 Aug;136(2):223-30.
122. Kwok AK, Lee VY, Lai TY, Hon C. Laser induced chorioretinal venous anastomosis
in ischaemic central retinal vein occlusion. Br J Ophthalmol. 2003 Aug;87(8):1043-4.
123. Kwok AK, Lai TY. Internal limiting membrane removal in macular hole surgery
for severely myopic eyes: a case-control study. Br J Ophthalmol. 2003 Jul;87(7):885-9. 124. Lai TY, Wong VW, Leung GM. Is ophthalmology evidence based? A clinical audit
of the emergency unit of a regional eye hospital. Br J Ophthalmol. 2003 Apr;87(4):385-90. Review.
125. Kwok AK, Lai TY, Man-Chan W, Woo DC. Indocyanine green assisted retinal
internal limiting membrane removal in stage 3 or 4 macular hole surgery. Br J Ophthalmol. 2003 Jan;87(1):71-4.
126.Yam HF, Kwok AK, Chan KP, Lai TY, Chu KY, Lam DS, Pang CP. Effect of indocyanine
green and il umination on gene expression in human retinal pigment epithelial cel s. Invest Ophthalmol Vis Sci. 2003 Jan;44(1):370-7.
127. Kwok AK, Lai TY, Yip WW. Correlation of clinical and optical coherence
tomography findings in postoperative macular hole closure status. Ophthalmic Surg Lasers Imaging. 2003 Jan-Feb;34(1):25-32.
128. Kwok AK, Li KK, Lai TY, Lam DS. Pars plana vitrectomy in the management of
retained intravitreal lens fragments after cataract surgery. Clin Experiment Ophthalmol. 2002 Dec;30(6):399-403.
129. Kwok AK, Lai TY, Chan CW, Neoh EL, Lam DS. Polypoidal choroidal vasculopathy
in Chinese patients. Br J Ophthalmol. 2002 Aug;86(8):892-7. Review.
130. Kwok AK, Lai TY. ILM peeling in macular hole surgery. Ophthalmology. 2002

131. Lee VY, Cheung BT, Lai TY, Yuen CY, Kwok AK, Lam DS. Acrylic intraocular lens
placement in conjunction with pars plana vitrectomy. Am J Ophthalmol. 2002 Apr;133(4):586; author reply 586-7.
132. Kwok AK, Lam SW, Lai TY, Lam DS. Endophotocoagulation to retinal pigment
epithelium as an adjuvant therapy in the management of retinal detachment caused by a highly myopic macular hole. Ophthalmic Surg Lasers. 2002 Mar-Apr;33(2):155-7.
133. Kwok AK, Li WW, Pang CP, Lai TY, Yam GH, Chan NR, Lam DS. Indocyanine green
staining and removal of internal limiting membrane in macular hole surgery: histology and outcome. Am J Ophthalmol. 2001 Aug;132(2):178-83.
134. Lai TY, Kwok AK, Fung KS, Chan WM, Fan DS, Lam DS. Stenotrophomonas
maltophilia endophthalmitis after penetrating injury by a wooden splinter. Eye (Lond). 2001 Jun;15(Pt 3):353-4.
135. Kwok AK, Lai TY, Neoh EL, Lee RW, Lam DS. Sub-Tenon's injection for posterior
segment surgery. Ophthalmology. 2001 Jun;108(6):1006-7; author reply 1007-8.
136. Lai TY, Kwok AK, Lam DS. Disinfection of vacuum control manifold to prevent
postoperative endophthalmitis. Ophthalmology. 2001 Apr;108(4):636-7.
137. Kwok AK, Lai TY, Cheng AC, Lam DS. Massive subretinal haemorrhage associated
with central serous chorioretinopathy. Eye (Lond). 2001 Feb;15(Pt 1):121-3.
138. Kwok AK, Li JZ, Lai TY, Chan WM, Bhende P, Lam DS. Multifocal
electroretinographic and angiographic changes in pre-eclampsia. Br J Ophthalmol. 2001 Jan;85(1):111-2.
139. Kwok AK, Lai TY, Shetty NS, Lam DS. Central serous chorioretinopathy
complicated by massive bilateral subretinal haemorrhage. Br J Ophthalmol. 2000 Aug;84(8):936-7.
140. Lai TY, Kwok AK, Lam DS, Bhende P. Progression of diabetic retinopathy after
endophthalmitis. Ophthalmology. 2000 Apr;107(4):619-21.
141. Lai TY, Leung AT, Lam DS. Primary orbital Ewing sarcoma in a middle-aged
woman. Arch Ophthalmol. 2000 Apr;118(4):592.

Source: http://www.2010eye.com.hk/download/professional_list_dr_lai.pdf

Generated pdf of zf_interoele

Manual and automatic transmissionsfor trucks, buses and light commercial vehicleswith "TE-ML 02" entry on the type plate   1.4 Product groups/Models/Versions from the past, not individually listed5. Lubricant classes and approved trade products 1. Approved lubricant classes 1.1 Trucks and special applications Note: Instead of the “0“ as the last figure, thereThe list of lubric

Drink contents

DRINK CONTENTS How much sugar is in XS drink? There is less than 1/2 calorie (2 kilojoules) of sugar in XS Energy Drink. The 8 calories in XS are from amino acids and are protein calories that are used in your body’s natural metabolic process. Most 250 energy drinks in the market today have over 100 calories from 27-30 grams of sugar,(approximately 7 teaspoons of sugar) whi

Copyright © 2010-2014 Medical Pdf Finder